INTECH Investment Management’s Cidara Therapeutics CDTX Stock Holding History

INTECH Investment Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,489	Closed	-$1.65M	–	2139
2025 Q4	$1.65M	Buy	7,489 +1,508	+25%	+$244K	0.01%	842
2025 Q3	$573K	Sell	5,981 -3,021	-34%	-$193K	0.01%	1500
2025 Q2	$438K	Buy	+9,002	New	+$216K	﹤0.01%	1682

INTECH Investment Management's CDTX Position: Q1 2026 in Review

INTECH Investment Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 7,489 shares — an estimated $1.65M sold.

INTECH Investment Management first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $1.65M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

INTECH Investment Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
INTECH Investment Management sold 7,489 Cidara Therapeutics shares in Q1 2026, an estimated $1.65M.
INTECH Investment Management first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
INTECH Investment Management's Cidara Therapeutics position peaked at $1.65M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.